Trulieve Cannabis Completes Acquisition of Pennsylvania Dispensary Operator

Trulieve Cannabis Corp. (TCNNF) completed the acquisition of assets from a Pennsylvania medical marijuana dispensary operator, the company reported in an 8-K filed with the SEC on June 4 2026.

The filing discloses entry into a material definitive agreement and the closing of the transaction under Items 1.01 and 2.01. Per the document, the deal involved a combination of cash and stock consideration, though the exact amount is detailed in exhibits filed with the report. Item 9.01 includes the required financial statements and pro forma information reflecting the acquisition.

The transaction expands Trulieve’s operational footprint in Pennsylvania, one of the states with a capped number of medical marijuana retail licenses. Prior to the deal Trulieve held a limited number of dispensary locations in the state; the acquired assets increase that count and associated patient access points.

The filing does not disclose the precise number of dispensaries transferred or the pre-deal revenue of the target.

Operationally the acquired business now falls under Trulieve’s consolidated operations effective June 4 2026. The company must integrate the acquired licenses, inventory, and staff under Pennsylvania Department of Health regulations that govern medical marijuana dispensaries. Updated financial results incorporating the acquisition will appear in Trulieve’s next periodic report.

Downstream the filing starts the clock for any required Hart-Scott-Rodino antitrust termination notices if not previously cleared and for state regulatory notifications confirming the change of ownership. Markets and counterparties now have official SEC confirmation of the closed transaction, allowing updated valuations and debt-covenant calculations.

The exhibits filed today also become the baseline for any subsequent SEC comments or state licensing reviews that reference the purchase price or terms.

This marks Trulieve’s latest move to consolidate retail assets inside limited-license jurisdictions following similar acquisitions in Florida and other states over the past 24 months. The company has used 8-K filings to disclose each material purchase as required under Item 2.01 once the deals close.

Primary sources: SEC Form 8-K filed June 4 2026 (Accession No. 0001754195-26-000033).